NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 71 filers reported holding NEURODERM LTD in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $367,000 | -58.2% | 9,437 | -67.8% | 0.00% | -100.0% |
| Q2 2017 | $877,000 | +47.4% | 29,320 | +30.9% | 0.00% | – |
| Q1 2017 | $595,000 | +37.4% | 22,400 | +14.9% | 0.00% | – |
| Q4 2016 | $433,000 | +168.9% | 19,498 | +123.7% | 0.00% | – |
| Q3 2016 | $161,000 | +13.4% | 8,717 | 0.0% | 0.00% | – |
| Q2 2016 | $142,000 | +115.2% | 8,717 | +86.4% | 0.00% | – |
| Q1 2016 | $66,000 | -17.5% | 4,676 | 0.0% | 0.00% | – |
| Q4 2015 | $80,000 | – | 4,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 826,799 | $11,674,000 | 6.53% |
| Foresite Capital Management III, LLC | 292,371 | $4,128,000 | 3.19% |
| Avoro Capital Advisors LLC | 537,477 | $7,589,000 | 2.65% |
| Redmile Group, LLC | 1,180,887 | $16,674,000 | 1.71% |
| NEXTHERA CAPITAL LP | 70,000 | $988,000 | 1.02% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,383,359 | $47,773,000 | 0.89% |
| Foresite Capital Management II, LLC | 119,781 | $1,691,000 | 0.83% |
| SENZAR ASSET MANAGEMENT, LLC | 215,400 | $3,041,448,000 | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 166,359 | $2,349,000 | 0.51% |
| Opaleye Management Inc. | 38,500 | $544,000 | 0.34% |